Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
Giuseppe Di Lorenzo, Silvia Zappavigna, Felice Crocetto, Mario Giuliano, Dario Ribera, Rocco Morra, Luca Scafuri, Antonio Verde, Dario Bruzzese, Simona Iaccarino, Ferdinando Costabile, Livia Onofrio, Martina Viggiani, Alessandro Palmieri, Pietro De Placido, Antonella Lucia Marretta, Erica Pietroluongo, Amalia Luce, Marianna Abate, Zahrasadat Navaeiseddighi, Vincenzo Caputo, Giuseppe Celentano, Nicola Longo, Matteo Ferro, Franco Morelli, Gaetano Facchini, Michele Caraglia, Sabino De Placido, Carlo Buonerba
Topics & Concepts
Interquartile rangeMedicineProstate cancerEnzalutamideCirculating tumor cellPTENInternal medicineAndrogen deprivation therapyBiomarkerOncologyProspective cohort studyAndrogen receptorUrologyCancerGastroenterologyMetastasisBiologyApoptosisBiochemistryPI3K/AKT/mTOR pathwayProstate Cancer Treatment and ResearchMultiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics